Press releases

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area GALWAY, Ireland, March 23, 2026 /PRNewswire/ -- Medtronic plc (NYSE:...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on the Nasdaq Global Select Market (Nasdaq) under...

A new real-world retrospective analysis published in Diabetes Care showed that users of the MiniMed™ 780G system achieved American Diabetes Association (ADA) recommended goals for time-in-range...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual J.P. Morgan healthcare conference on Monday, January 12, 2026. Geoff...

Symplicity blood pressure procedure is now covered for qualifying Medicare patients GALWAY, Ireland, Oct. 28, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the American Hernia Society annual meeting GALWAY, Ireland and NASHVILLE, Tenn.,

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the following investor conferences: 2025 Wells Fargo Healthcare Conference Thursday,...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, August 19, 2025, for its first quarter of fiscal year 2026,...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an...

Data supports the potential of future indication expansion for the MiniMed™ 780G system. LENNY trial results published in Lancet Diabetes & Endocrinology. GALWAY, Ireland and CHICAGO, June 20,...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2025 on Wednesday, May 21,...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Data shows, versus surgery, the...

Delivering durable revenue growth with strong earnings power; strength in Pulsed Field Ablation, Pacing, Structural Heart, Diabetes, and Neuromodulation GALWAY, Ireland, Feb. 18, 2025 /PRNewswire/...

European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease GALWAY, Ireland, Jan. 13, 2025...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025. Geoff...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2025 on Tuesday, November 19, 2024....

The Symplicity ™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure GALWAY, Ireland, Nov. 1, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global...

Company commits to advancing clinical data for Symplicity™ with the SPYRAL Gemini clinical trial and expansion of the GSR-DEFINE clinical trial GALWAY, Ireland and WASHINGTON, Oct. 28, 2024...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024. Geoff Martha,...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 45th annual Goldman Sachs global healthcare conference on Tuesday, June 11, 2024....

Fast Company announced that the Medtronic MiniMed™ 780G automated insulin delivery system has been recognized in the Best World-Changing Idea, North America category as part of the 2024 World...

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2024 on Thursday, May 23,...

According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues DUBLIN, April 17,...

AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy DUBLIN, April 10, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT),...

Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced that the Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed the validity of...

New data presented at ATTD demonstrates the system's ability to help individuals with type 1 diabetes exceed international targets on outcome measures DUBLIN and FLORENCE, Italy, March 9, 2024...

The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 7, 2024, approved the company's cash dividend for the fourth quarter of fiscal year 2024 of $0.69 per ordinary share. This...

Agreement expands partnership between Medtronic and Cosmo Pharmaceuticals, set to transform endoscopy with cutting-edge AI technology DUBLIN, Dec. 11, 2023 /PRNewswire/ -- Medtronic plc (NYSE:...

The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 7, 2023, approved the company's cash dividend for the third quarter of fiscal year 2024 of $0.69 per ordinary share. This...

According to a new survey from Medtronic and Morning Consult, respondents recognize potential of AI to enable earlier diagnosis and improve access to care DUBLIN, Nov. 13, 2023 /PRNewswire/ --...

The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Medtronic plc...

Today, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity...

Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced its participation in the upcoming American Diabetes Association's (ADA) 83rd Scientific Sessions in San Diego on...

Recognition honors companies demonstrating business integrity through best-in-class ethics, compliance, and governance practices DUBLIN, March 13, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a...

Strong environmental, social, and governance (ESG) management and performance result in continued inclusion on the Dow Jones Sustainability World Index DUBLIN, Dec. 14, 2022 /PRNewswire/ --...

The board of directors of Medtronic plc (NYSE: MDT) on Friday, December 11, 2020, approved the fiscal year 2021 third quarter cash dividend of $0.58 per ordinary share. This quarterly declaration...

DUBLIN - December 29, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 36th Annual J.P. Morgan Healthcare Conference on Monday,...

DUBLIN - December 19, 2017 - Medtronic plc (NYSE: MDT) announced today that Bob White, previously Senior Vice President and President of Medtronic's Asia Pacific (APAC) Region, has been named...

DUBLIN - December 8, 2017 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 third quarter cash dividend of $0.46 per ordinary share, representing a 7 percent...

DUBLIN - December 1, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Citi 2017 Global Healthcare Conference on Wednesday,...

DUBLIN - November 27, 2017 - Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business commenced launch of new telehealth solutions in support of its national...

DUBLIN - November 21, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2018, which ended October 27, 2017. The company reported second...

DUBLIN - November 20, 2017 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with...

DUBLIN - November 13, 2017 - Medtronic plc (NYSE: MDT) today announced several noteworthy presentations of clinical studies and symposia on aortic, peripheral, endoVenous, and vascular...

DUBLIN - November 8, 2017 - Medtronic plc (NYSE: MDT) today announced its preliminary revenue for its second quarter of fiscal year 2018, which ended October 27, 2017. The company announced...

DUBLIN - November 6, 2017 - Medtronic plc (NYSE:MDT) today announced that it received CE (Conformité Européenne) Mark for the Intellis(TM) platform for both Spinal Cord Stimulation (SCS) and...

DUBLIN and DENVER - November 2, 2017 - Medtronic plc (NYSE:MDT) today presented new data at the Transcatheter Cardiovascular Therapeutics (TCT) Annual Meeting showcasing the excellent clinical...

DUBLIN - November 2, 2017 - Medtronic plc (NYSE:MDT) announces the release of its fiscal year 2017 Integrated Performance Report. The report highlights the combined financial, social, and...

DUBLIN and DENVER - November 1, 2017 - Investigators today unveiled clinical data from the independently run DAPT-STEMI trial, which found no difference in patient outcomes between six-and...

DUBLIN and DENVER - November 1, 2017 - Medtronic plc (NYSE:MDT) today presented positive data for its self-expanding Intrepid(TM) transcatheter mitral valve replacement (TMVR) system in patients...

DUBLIN and DENVER - October 31, 2017 - Medtronic plc (NYSE:MDT) today presented new clinical research to support the positive clinical performance of the Evolut(TM) Transcatheter Aortic Valve...

DUBLIN - October 25, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced data from the first economic analysis conducted on the use of professional continuous...

DUBLIN - October 23, 2017 - Medtronic plc (NYSE:MDT) today announced the first patient implant in the APOLLO Trial - the pivotal trial designed to evaluate the Intrepid(TM) TMVR system following...

DUBLIN and BOSTON - October 16, 2017 - Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business and American Well® entered into a first-of-its-kind...

DUBLIN and ST. LOUIS - October 13, 2017 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and Mercy, the fifth largest Catholic health care system in the U.S., together will...

DUBLIN - October 9, 2017 - Medtronic plc (NYSE: MDT) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the Endurant(TM) II/IIs stent graft system to treat...

DUBLIN and CHENGDU, Sichuan - October 10, 2017 - Medtronic plc (NYSE:MDT) today announced the groundbreaking of its Chengdu Innovation Center at the Singapore-Sichuan Hi-Tech Innovation Park in...

DUBLIN - October 6, 2017 - Medtronic plc (NYSE: MDT) today provided an update on the impact to its manufacturing and sales operations as a result of Hurricane Maria. All four of the company's...

DUBLIN - September 27, 2017 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) approval for its HeartWare(TM) HVAD(TM) System as a destination therapy for patients...

DUBLIN - September 21, 2017 - Medtronic plc (NYSE: MDT) today announced a new post-market clinical study to evaluate its CoreValve(TM) Evolut(TM) PRO valve in everyday clinical practice. Studying...

DUBLIN - September 18, 2017 - Medtronic plc (NYSE:MDT) today announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain....

DUBLIN - September 14, 2017 - Long distance running is never easy. But for twenty long-distance runners participating in the Medtronic Twin Cities Marathon Weekend, just toeing the starting line...

DUBLIN and LAS VEGAS - September 13, 2017 - Medtronic plc (NYSE: MDT) today reported its Endurant® II abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term...

DUBLIN - September 12, 2017 - Medtronic plc (NYSE: MDT) today announced the global launch of the StealthStation(TM) ENT, a new surgical navigation system designed for surgeons treating conditions...

DUBLIN and LAS VEGAS - September 12, 2017 - Medtronic plc (NYSE: MDT) data announced today reinforce the durability and safety of the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) in patients...

DUBLIN - September 11, 2017 - Medtronic plc (NYSE:MDT) announced today that it has started to inform patients worldwide of a voluntary recall of specific lots of infusion sets used with all models...

DUBLIN - September 8, 2017 - Medtronic plc (NYSE: MDT) today announced that the IN.PACT(TM)Admiral(TM) Drug-Coated Balloon (DCB) received approval from the Japanese Ministry of Health, Labour and...

DUBLIN - September 7, 2017 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability North...

PORTSMOUTH, N.H., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Medtronic (NYSE:MDT), a global medical device company with offices at the Pease Tradeport in Portsmouth, has been named the Best Company to...

DUBLIN - September 7, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 15th Annual Morgan Stanley Global Healthcare...

DUBLIN - September 5, 2017 - Medtronic plc (NYSE: MDT) today announced the launch of a long term clinical study program to collect prospective data on INFUSE® Bone Graft in Posterolateral Fusion...

DUBLIN - September 5, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 2017 Wells Fargo Healthcare Conference on Thursday,...

DUBLIN and BARCELONA - August 28, 2017 - Medtronic plc (NYSE:MDT) today announced its intent to move forward with a new renal denervation pivotal trial following positive first results from a...

DUBLIN - August 25, 2017 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2018 second quarter cash dividend of $0.46 per ordinary share, representing a 7 percent...

DUBLIN - August 22, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2018, which ended July 28, 2017. The company reported first quarter...

DUBLIN - August 21, 2017 - Medtronic plc (NYSE: MDT) announced it has received CE (Conformité Européene) Mark for the Attain Stability(TM) Quad MRI SureScan(TM) left heart lead. Paired with...

DUBLIN - August 17, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the CFA Society Minnesota's 6th Annual Investor Conference,...

DUBLIN - August 15, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the first quarter fiscal year 2018 on Tuesday, August 22, 2017. A news release will...

DUBLIN- August 14, 2017 - Medtronic plc (NYSE: MDT) today announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT) - the combination of aspirin...

DUBLIN - August 2, 2017 - Medtronic plc (NYSE: MDT) today announced CE (Conformité Européenne) mark and U.S. Food and Drug Administration (FDA) approval of its new Avalus(TM) pericardial aortic...

DUBLIN - August 1, 2017 - A new health economic analysis from the landmark FIRE AND ICE Trial, sponsored by Medtronic plc (NYSE: MDT), was published today in the Journal of the American Heart...

DUBLIN - July 31, 2017 - Medtronic plc (NYSE:MDT) today announced CE (Conformité Européenne) mark and European launch of the CoreValve(TM)Evolut(TM) PRO valve for the treatment of severe aortic...

DUBLIN - July 30, 2017 - Medtronic plc (NYSE: MDT) today announced that it has completed the previously announced sale of its Patient Care, Deep Vein Thrombosis (Compression), and Nutritional...

DUBLIN - July 17, 2017 - Medtronic plc (NYSE: MDT) today announced that the InterStim(TM) system, which provides sacral neuromodulation therapy, offers sustained long-term efficacy and quality of...

DUBLIN - July 11, 2017 - Medtronic plc (NYSE: MDT) today announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the safety and effectiveness of performing...

DUBLIN - July 10, 2017 - Medtronic plc (NYSE: MDT) today announced the expanded U.S. Food and Drug Administration (FDA) approval of the self-expanding CoreValve(TM) Evolut(TM) transcatheter aortic...

DUBLIN and BERLIN - June 28, 2017 - Medtronic plc (NYSE: MDT) today announced it has received CE (Conformité Européenne) Mark for SureTune(TM)3 software for deep brain stimulation (DBS)....

DUBLIN - June 26, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a new outcomes-based agreement with Aetna (NYSE:AET) for type 1 and type 2 diabetes...

DUBLIN - June 23, 2017 - The board of directors of Medtronic plc (NYSE: MDT) today approved a 7 percent increase in its quarterly cash dividend, raising the quarterly amount to $0.46 per ordinary...

DUBLIN and VIENNA - June 20, 2017 - Medtronic plc (NSYE: MDT) today announced new data showing that use of its cardiac resynchronization therapy (CRT) devices - with its proprietary AdaptivCRT(TM)...

DUBLIN and VIENNA - June 18, 2017 - Continuing its leadership in the detection, reduction, and treatment of atrial fibrillation (AF), Medtronic plc (NYSE: MDT) today announced that its Reactive...

DUBLIN - June 7, 2017 - Medtronic plc (NYSE:MDT), today announced the U.S. launch of the MiniMed(TM) 670G system - the world's first Hybrid Closed Loop system for people with type 1 diabetes....

DUBLIN - June 6, 2017 - Medtronic plc (NYSE: MDT) today announced it has received a Health Canada licence for SureTune(TM)3 software for deep brain stimulation (DBS). The latest innovations in the...

DUBLIN - June 6, 2017 - Medtronic (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the 77th Scientific Sessions of...

DUBLIN - May 31, 2017 - Medtronic plc (NYSE: MDT) recently launched PRODIGY, a 1,650-patient global study, to identify individuals at high risk for opioid induced respiratory depression (OIRD), a...

DUBLIN - May 25, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2017, which ended April 28, 2017. The company reported fourth quarter...

DUBLIN - May 24, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 38th Annual Goldman Sachs Global Healthcare Conference on...

DUBLIN - May 24, 2017 - Medtronic plc (NYSE: MDT) today announced that the first patient has been enrolled in the IN.PACT(TM) AV Access Drug-Coated Balloon (DCB) study for use in patients with...

DUBLIN and PARIS- May 18, 2017 - Medtronic plc (NYSE: MDT) today announced that the Resolute Onyx(TM) Drug-Eluting Stent (DES) met its primary endpoint of Target Lesion Failure (TLF) at one year...

DUBLIN and CHICAGO- May 17, 2017 - A new Medtronic plc (NYSE: MDT) study shows a high use of app-based remote cardiac monitoring among older patients. Presented at Heart Rhythm 2017, the Heart...